B. Munipalli

发表

Postacute Sequelae of SARS-CoV-2 Infection—Lessons Learned From a Coordinated Health System Response

I. Croghan, A. A. Abu Dabrh, R. Hurt, 2022, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

Unusual presentation of stiff-person syndrome in a patient with type 1 diabetes mellitus

B. Munipalli, Jaimin S. Shah, 2022, BMJ Case Reports.

Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia

D. Hodge, A. A. Abu Dabrh, A. Abril, 2022, Journal of primary care & community health.

Neurophenotypes of COVID-19: risk factors and recovery trajectories

A. Athreya, K. Blackmon, G. Day, 2022, Research square.

Cokeromyces recurvatus isolated from pleural and peritoneal fluid: case report

M. Rinaldi, S. Greenberg, B. Munipalli, 1996, Journal of clinical microbiology.

Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience

M. Heckman, A. A. Abu Dabrh, D. Trifiletti, 2021, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

Ipodate therapy in patients with severe destruction-induced thyrotoxicosis.

R. Arem, B. Munipalli, Bala Munipalli, 1996, Archives of internal medicine.

Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management

Abd Moain Abu Dabrh, N. Dawson, Lynsey A. Seim, 2022, SN Comprehensive Clinical Medicine.

Prevalence, Demographics, and Risk of Severe Acute COVID-19

A. A. Abu Dabrh, I. Logvinov, B. Munipalli, 2021, Cureus.

Neurophenotypes of COVID-19: risk factors and recovery outcomes

A. Athreya, K. Blackmon, G. Day, 2022, Research square.

Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19

Abd Moain Abu Dabrh, S. Hines, I. Logvinov, 2022, The American Journal of the Medical Sciences.

Association of Vitamin B12, Vitamin D, and Thyroid-Stimulating Hormone With Fatigue and Neurologic Symptoms in Patients With Fibromyalgia

A. A. Abu Dabrh, N. Dawson, P. Malavet, 2022, Mayo Clinic proceedings. Innovations, quality & outcomes.

Neurophenotypes of COVID-19: Risk factors and recovery outcomes

A. Athreya, K. Blackmon, G. Day, 2023, Brain, behavior, & immunity - health.

Clinical differences in symptomology, characteristics, and risk factors in patients with post-acute sequelae of COVID-19: an experience from a tertiary-care academic center

A. A. Abu Dabrh, Zhuo Li, A. Mohabbat, 2023, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting

K. Downes, S. Hines, I. Logvinov, 2021, SN Comprehensive Clinical Medicine.

High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities

T. Rozen, D. Fairweather, B. Bruce, 2023, Frontiers in Medicine.

Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned

T. Rozen, D. Fairweather, N. Dawson, 2022, SN Comprehensive Clinical Medicine.

Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study

D. Fairweather, Angita Jain, K. A. Bruno, 2024, Frontiers in cardiovascular medicine.

A description of the development of an innovative multi-component long COVID treatment program based on central sensitization with preliminary patient satisfaction data.

B. Munipalli, A. Smith, A. R. Baird, 2024, Journal of psychosomatic research.